| Brainstorm | New from MedPageToday: FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers: (MedPage Today) -- The FDA granted accelerated approval to the bispecific antibody zenocutuzumab (Bizengri) for NRG1 gene fusion-positive pancreatic adenocarcinoma and non-small cell lung cancer (NSCLC) on [... want %more?] → https://www.medpagetoday.com/hematologyoncology/lungcancer/113222 | 00:28 |
|---|---|---|
| de-facto | https://x.com/MinSanteDRC/status/1864089204784791922 | 01:32 |
| de-facto | https://pastebin.com/vrkhgnLJ | 01:35 |
| Brainstorm | New from BMJ: Direct-to-consumer tests: emerging trends are cause for concern: Advances in diagnostic technology and digital health have increased the variety and volume of direct-to-consumer tests—commercial tests initiated by consumers without clinical consultation.1 Sales of these tests have surged from $15m in 2010 [... want %more?] → http://www.bmj.com/content/387/bmj-2024-080460.short | 01:36 |
| Brainstorm | New from BMJ Open: Impact of the COVID-19 pandemic on the National Telehealth Service for triage and referral in Sweden: a national retrospective observational study: Objectives Telehealth, the provision of healthcare through digital communication, has been proposed as a potential solution to meet the increasing demand [... want %more?] → http://bmjopen.bmj.com/cgi/content/short/14/12/e091627 | 01:56 |
| Brainstorm | New from EMA: What's new: (news): Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 33, Status: Withdrawn (authorisation) → https://www.ema.europa.eu/en/medicines/human/EPAR/jcovden | 09:58 |
| Brainstorm | New from PubMed: COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity: INTRODUCTION: Chronic myeloid leukemia (CML) is a severe hematological malignancy characterized by BCR-ABL fusion gene. The advent of tyrosine kinase inhibitors (TKIs) targeting BCR-ABL has improved the landscape of [... want %more?] → https://pubmed.ncbi.nlm.nih.gov/39635534/ | 12:25 |
| de-facto | %title https://www.euronews.com/health/2024/12/03/uk-purchases-5-million-bird-flu-vaccine-doses-to-prepare-for-possible-pandemic | 12:54 |
| Brainstorm | de-facto: From www.euronews.com: UK purchases 5 million bird flu vaccine doses to prepare for possible pandemic | Euronews | 12:54 |
| Brainstorm | New from EMA: What's new: (news): Human medicines European public assessment report (EPAR): Supemtek, Quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 6, Status: Authorised → https://www.ema.europa.eu/en/medicines/human/EPAR/supemtek | 13:53 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): 4a. The activated B cells need to be made better, switching to the most suitable antibody types, and mutating these to the perfect fit. → https://mastodon.online/@marc_veld/113600341515081530 | 14:04 |
| Brainstorm | New from r/WorldNews: worldnews: Voters want more US involvement on world stage despite isolationist talk, Ronald Reagan Institute survey finds → https://old.reddit.com/r/worldnews/comments/1h792fj/voters_want_more_us_involvement_on_world_stage/ | 14:42 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): A 24-month National Cohort Study examining long-term effects of COVID-19 in children and young people → https://mastodon.online/@marc_veld/113600761293536467 | 15:52 |
| Brainstorm | New from Contagion Live: us: Merck and Ridgeback Biotherapeutics Announce Phase 3 Study for COVID-19 Antiviral for High-Risk Adults → https://www.contagionlive.com/view/merck-and-ridgeback-biotherapeutics-announce-phase-3-study-for-covid-19-antiviral-for-high-risk-adults | 16:12 |
| Brainstorm | New from StatNews: AstraZeneca replaces benched exec in China: Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we see a federal agency change its… → https://www.statnews.com/2024/12/05/biotech-news-astrazeneca-atlas-venture-leptin-patent-thickets-the-readout/ | 16:52 |
| Brainstorm | New from Contagion Live: Navigating Uncertainty And Raising Awareness About Long COVID: The complex and often frustrating realities that patients face when dealing with a post-infection condition that remains misunderstood by many continue to unfold. → https://www.contagionlive.com/view/navigating-uncertainty-and-raising-awareness-about-long-covid | 17:02 |
| Brainstorm | New from r/Science: science: Modelling study based on almost 250,000 positive COVID-19 tests in the United Kingdom shows that universal masking could have cut transmission markedly. → https://old.reddit.com/r/science/comments/1h7cnja/modelling_study_based_on_almost_250000_positive/ | 17:32 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): Again, these are largely expected patterns. This does not mean SARS-CoV-2 will be gone, we will get another wave regularly. The question of where in the viral calendar it will settle, and what the consequences are for the schedule of other viruses remain open questions. → https://mastodon.online/@marc_veld/113601349521235949 | 18:21 |
| Brainstorm | New from New Scientist: H5N1 bird flu is closer to gaining pandemic potential than we thought: The flu virus currently circulating in birds and dairy cows is already better at infecting people than earlier variants, and a single mutation would allow it to [... want %more?] → https://www.newscientist.com/article/2459077-h5n1-bird-flu-is-closer-to-gaining-pandemic-potential-than-we-thought/ | 20:27 |
| Brainstorm | New from Contagion Live: us: COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population → https://www.contagionlive.com/view/covid-19-therapy-roundtable-what-is-the-virus-today-treatment-options-and-addressing-the-pediatric-population | 21:45 |
| Brainstorm | New from CIDRAP: Study: Higher risk of accompanying bacterial infections with flu, RSV than SARS-CoV-2: But the risk of bacterial infections in COVID-19 patients was substantially elevated after 48 hours compared with the other viruses. → https://www.cidrap.umn.edu/antimicrobial-stewardship/study-higher-risk-accompanying-bacterial-infections-flu-rsv-sars-cov-2 | 22:05 |
| Brainstorm | New from MedPageToday: Psilocybin Cut Depression Symptoms in COVID's Frontline Healthcare Workers: (MedPage Today) -- Psilocybin therapy reduced depression symptoms in clinicians who developed these symptoms after frontline clinical work during the COVID-19 pandemic, a small randomized trial showed.At day 28, the [... want %more?] → https://www.medpagetoday.com/psychiatry/depression/113239 | 23:33 |
Generated by irclog2html.py 2.17.0 by Marius Gedminas - find it at https://mg.pov.lt/irclog2html/!